| May 19, 2013
| 8:22 AM
WASHINGTON -- Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a...
| Oct 17, 2012
| 3:19 PM
Human Genome Sciences Inc., which was acquired for $3.6 billion by London-based GlaxoSmithKline Plc in August, intends to lay off 97 employees in mid-December, and an additional but unspecified number of cuts are planned for next year, the company...
| Feb 20, 2013
| 3:50 PM
Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market.
The company also withheld data that showed the drugs...
| Sep 5, 2012
| 12:45 PM
Rockville-based Human Genome Sciences has warned state regulators that it plans to cut 114 jobs beginning in October, three months after striking a deal to be acquired by GlaxoSmithKline.
Human Genome, which employs about 1,000 people in Rockville, could...
| Sep 20, 2011
| 8:52 AM
ZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis.
Roche's T-DM1 and Novartis's Afinitor...
| Feb 1, 2012
| 1:52 PM
Upon learning they are pregnant, most women dutifully nix the alcohol, sushi and caffeine.
But what about antidepressants?
Headlines about the potential risks of antidepressants on a developing fetus, including miscarriage, premature birth and newborn...
| Jan 23, 2012
| 9:18 AM
NEW YORK (Reuters Health) - Young women on birth control pills tend to have less painful menstrual periods than those not on the contraceptives, a new study finds.
Swedish researchers found that of 2,100 women followed from age 19 to 24, those on the...
| Feb 26, 2012
| 11:45 PM
NEW YORK (Reuters Health) - Boys 11 years and up should get Merck & Co's Gardasil vaccine to protect them against HPV infections, which can cause genital warts as well as oral, penile and anal cancers, the nation's largest group of pediatricians said...
| Oct 25, 2011
| 2:21 PM
NEW YORK (Reuters Health) - One class of drugs used to prevent wheezing and shortness of breath in people with asthma may increase kids' risk of being hospitalized for an asthma attack, according to a new analysis from the U.S. Food and Drug...
| Nov 24, 2011
| 12:41 PM
LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil.
The move underscores Gardasil's lead in a $1 billion-plus worldwide...
| Apr 21, 2012
| 11:26 AM
Like a one-two punch, two major Maryland employers in the health care service and pharmaceutical industries were the targets last week of multibillion-dollar acquisition deals.
Both homegrown companies — Human Genome Sciences Inc. and Catalyst...